Form 4: BioCardia CEO Peter Altman Acquires 500 Shares of Common Stock
SEC Form 4
BioCardia's President and CEO, Peter Altman, purchased 500 shares of the company's common stock at a price of $0.39 per share on March 28, 2024.
Summary
- On March 28, 2024, Peter Altman, the President and CEO of BioCardia, Inc., acquired 500 shares of common stock.
- The purchase price was $0.39 per share.
- Following the transaction, Altman directly owns 555,947 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO buying shares is generally a good sign, but the small quantity of shares purchased limits the impact on sentiment.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal about their confidence in the company's future prospects.
Industry Context
Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's valuation and future performance. It is a common practice and is regulated to prevent illegal activities such as trading on non-public information.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction: Peter Altman acquired 500 shares of BioCardia common stock. |
Keywords
BioCardia, BCDA, Insider Trading, Stock Acquisition, Peter Altman, CEO, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.